[HTML][HTML] Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancer
JM Redman, J Friedman, Y Robbins… - The Journal of …, 2023 - Am Soc Clin Investig
BACKGROUND Head and neck squamous cell carcinoma not associated with HPV (HPV-
unrelated HNSCC) is associated with a high rate of recurrence and poor survival …
unrelated HNSCC) is associated with a high rate of recurrence and poor survival …
[HTML][HTML] Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancer
JM Redman, J Friedman, Y Robbins… - The Journal of …, 2022 - ncbi.nlm.nih.gov
BACKGROUND Head and neck squamous cell carcinoma not associated with HPV (HPV-
unrelated HNSCC) is associated with a high rate of recurrence and poor survival …
unrelated HNSCC) is associated with a high rate of recurrence and poor survival …
Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancer.
JM Redman, J Friedman, Y Robbins, C Sievers… - 2022 - cabidigitallibrary.org
BACKGROUND. Head and neck squamous cell carcinoma not associated with HPV (HPV-
unrelated HNSCC) is associated with a high rate of recurrence and poor survival …
unrelated HNSCC) is associated with a high rate of recurrence and poor survival …
Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-b blockade in HPV-unrelated head and neck cancer
JM Redman, J Friedman, Y Robbins… - The Journal of …, 2022 - hsrc.himmelfarb.gwu.edu
BACKGROUND: Head and neck squamous cell carcinoma not associated with human
papillomavirus (HPV-unrelated HNSCC) is associated with high rates of recurrence and …
papillomavirus (HPV-unrelated HNSCC) is associated with high rates of recurrence and …
Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancer
JM Redman, J Friedman, Y Robbins… - Journal of Clinical …, 2022 - pure.johnshopkins.edu
Background. Head and neck squamous cell carcinoma not associated with HPV (HPV-
unrelated HNSCC) is associated with a high rate of recurrence and poor survival. Methods …
unrelated HNSCC) is associated with a high rate of recurrence and poor survival. Methods …
Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancer
JM Redman, J Friedman, Y Robbins… - The Journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
BACKGROUNDHead and neck squamous cell carcinoma not associated with HPV (HPV-
unrelated HNSCC) is associated with a high rate of recurrence and poor survival …
unrelated HNSCC) is associated with a high rate of recurrence and poor survival …
Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancer
JM Redman, J Friedman, Y Robbins… - Journal of Clinical …, 2022 - search.proquest.com
BACKGROUND. Head and neck squamous cell carcinoma not associated with HPV (HPV-
unrelated HNSCC) is associated with a high rate of recurrence and poor survival …
unrelated HNSCC) is associated with a high rate of recurrence and poor survival …
Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancer
JM Redman, J Friedman, Y Robbins… - The Journal of …, 2023 - Am Soc Clin Investig
BACKGROUND Head and neck squamous cell carcinoma not associated with HPV (HPV-
unrelated HNSCC) is associated with a high rate of recurrence and poor survival …
unrelated HNSCC) is associated with a high rate of recurrence and poor survival …
Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancer.
JM Redman, J Friedman, Y Robbins… - The Journal of …, 2022 - europepmc.org
BACKGROUND Head and neck squamous cell carcinoma not associated with HPV (HPV-
unrelated HNSCC) is associated with a high rate of recurrence and poor survival …
unrelated HNSCC) is associated with a high rate of recurrence and poor survival …
[PDF][PDF] Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-βblockade in HPV-unrelated head and neck cancer
JM Redman, J Friedman, Y Robbins, C Sievers… - 2022 - pdfs.semanticscholar.org
BACKGROUND. Head and neck squamous cell carcinoma not associated with HPV (HPV-
unrelated HNSCC) is associated with a high rate of recurrence and poor survival …
unrelated HNSCC) is associated with a high rate of recurrence and poor survival …